An Integrative Pharmacology Model for Decoding the Underlying Therapeutic Mechanisms of Ermiao Powder for Rheumatoid Arthritis
2022 · Frontiers in Pharmacology · 9 citations
https://doi.org/10.3389/fphar.2022.801350
X
Xiaowei Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
36
Papers
267
Citations
9
h-index
9
i10-index
Xiaowei Li is an academic researcher from Shandong University. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Rheumatoid Arthritis Research and Therapies & Systemic Lupus Erythematosus Research. The author has an h-index of 9, co-authored 31 publications.
ORCID: 0000-0002-1165-5251Papers by this author
worksComplete remission of metastatic osteosarcoma using combined modality therapy: a retrospective analysis of unselected patients in China
2021 · BMC Cancer · 8 citations
https://doi.org/10.1186/s12885-021-08071-5
[Effects of acupuncture on Bell's palsy patients in the acute stage based on the surface electromyography].
2025 · PubMed · 1 citations
https://doi.org/10.13702/j.1000-0607.20240016
Sequencing of the MHC region defines <i>HLA-DQA1</i> as the major independent risk for anti-citrullinated protein antibodies (ACPA)-positive rheumatoid arthritis in Han population
2018 · bioRxiv (Cold Spring Harbor Laboratory) · 0 citations
https://doi.org/10.1101/400937
Corrigendum: An integrative pharmacology model for decoding the underlying Therapeutic Mechanisms of Ermiao Powder for Rheumatoid arthritis
2023 · Frontiers in Pharmacology · 0 citations
https://doi.org/10.3389/fphar.2023.1302388
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat